In vitro activity of imipenem and ceftazidime against mucoid and non-mucoid strains of Pseudomonas aeruginosa isolated from patients in Iran

Archives of Iranian Medicine

Volumn 5, Issue 4, 2002, Pages 251-254

  Ahangarzadeh Rezaee, Mohammad ^a   Behzadiyan Nejad, Qorban ^a   Owlia, Parviz ^b   Najjar Pirayeh, Shahin ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Alginate; Ceftazidime; Imipenem; Pseudomonas aeruginosa

Indexed keywords

ALCOHOL; ALGINIC ACID; CEFTAZIDIME; IMIPENEM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHI SQUARE TEST; CONTROLLED STUDY; DATA ANALYSIS; HOSPITAL; IN VITRO STUDY; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRECIPITATION; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE;

EID: 0036823009     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid P. aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996; 60: 539-74.
2. Hodges NA, Gordon CA. Protection of P. aeruginosa against ciprofloxacin and β-lactams by homologous alginate. Antimicrob Agents Chemother. 1991; 35: 2450-2.
3. May TB, Shinabarger D, Maharaj R, et al. Alginate synthesis by P. aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev. 1991; 4: 191-206.
4. Bonfiglio G, Laksai Y, Franchino L, et al. Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrob Chemother. 1998; 42: 697-702.
5. Masuda N, Gotoh N, Ishii C, et al. Interplay between chromosomal β-lactamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams in P. aeruginosa. Antimicrob Agents Chemother. 1999; 43: 400-2.
6. Yu J, Penaloza-Vazquez A, Chakrabarty AM, et al. Involvement of the exopolysaccharide alginate in the virulence and epiphytic fitness of P. syringae pv. syringae. Mol Microbiol. 1999; 33: 712-20.
7. Govan JR, Fyfe JA. Mucoid P. aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother: 1978; 4: 233-40.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution of Antimicrobial Susceptibility Tests for Bacteria Grown Aerobically. 4th ed. Approved Standard M7- A4. Wayne PA, USA: NCCLS; 1997.
9. Gercekev AA, Otuk G. Comparison of imipenem and five other antipscudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa. Chemotherapy. 1995; 41: 334-6.
10. Garcia-Rodriguez JA, Blazquez AM, Fresnadillo MJ, et al. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and P. aeruginosa. J Chemother. 1996; 8: 358-64.
11. Minami S, Akama M, Araki H, et al. Imipenem and cephem-resistant P. aeruginosa carrying plasmids coding for class B beta-lactamase. J Antimicrob Chemother. 1996; 37: 433-44.
12. Baron EJ, Finegold SM. Diagnostic Microbiology. 8th ed. Missouri, USA: Mosby Company; 1990: 37-8.
13. Doig P, Smith NR, Todd T, et al. Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect Immun. 1987; 55: 1517-22.
14. Michael PR, Alford RH, McGee ZA. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant P. aeruginosa. Antimicrob Agents Chemother. 1981; 20: 702-41.
15. Vurma-Rapp U, Kayser FH, Barberis-Maino L. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant Staphylococci, cefotaxime-resistant Enterobacteriaceae and P. aeruginosa. J Antimicrob Chemother. 1986; 18(suppl E): 27-33.
16. Livermore DM. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol. 1987; 6: 439-45.
17. Yoshimura F, Nikaido H. Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother. 1985; 27: 84-92.
18. Behzadiyan-Nejad Q, Souri E, Owlia P. In vitro effects of subinhibitory concentrations of gentamicin on Pseudomonas aeruginosa alginate production. Pharm Pharmacol Commun. 1998; 4: 489-91.
19. Owlia P, Behzadiyan-Nejad Q, Souri E. Microscopic study of the effects of subinhibitory concentrations of gentamicin on capsule production of Pseudomonas aeruginosa. Arch Iranian Med. 2001; 4: 18-20.
20. Ahangarzadeh-Rezaee M, Behzadiyan-Nejad Q, Najjar-Pirayeh S. Higher aminoglycoside resistance in mucoid P. aeruginosa than in non-mucoid strains. Arch Iranian Med. 2002; 5: 108-10.
21. Slack MP, Nichols WW. The penetration of antibiotics through sodium alginate and through the exopolysaccharide of a mucoid strain of P. aeruginosa. Lancet. 1981; 2: 502-3.